Seasonal malaria vaccine study for elimination
Part of Infections clinical trials.
This trial tests a seasonal vaccination schedule with the R21 malaria vaccine to help eliminate malaria in your community. It may be a good fit if you are looking for a way to protect yourself or your child from malaria during peak transmission seasons.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be at least 5 months old.
- You must be willing to follow the study procedures and attend scheduled visits.
- You must provide written consent to participate.
- You cannot be pregnant.
- You must not have had a severe allergic reaction to any vaccine component (like neomycin or Kathon) or a history of anaphylaxis after vaccination.
- You must not have a known long-term illness or any other condition that the study doctor thinks could make participation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This study tests different doses and forms of a malaria vaccine to see which works best and is safest. It may help protect you from malaria for a full year.
This trial tests a new malaria vaccine in healthy children. It aims to see if the vaccine is safe and how well it works in children who have had their regular childhood shots.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study looks at whether malaria vaccines can also help lower the risk of a serious bacterial infection called invasive non-typhoidal Salmonella (iNTS). If you have a fever, you may be able to join and help researchers understand this connection.
This study compares two experimental malaria vaccines to see how safe they are and how well they protect adults. It may help future malaria prevention, and you would be closely monitored, including a malaria “challenge” test if you qualify.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.